Login Register
My Order
+86 180 14399 201 sales@chemlab-tachizaki.com
0
  • HOME
  • PRODUCTS
    • New Inhibitors&Agonists Polypeptide
    • Natural product
    • Dye/Fluorescent agent
    • ADC compound
    • PROTAC compound
    • Other compounds
    • Nucleosides
  • SERVICES
    • About Us
    • Contract Research Services
    • Analytical Services
    • Help find compounds
    • Preferential Scheme
    • Provide free reagent
  • LDISTRIBUTORS
  • CONTRACT RESEARCH SERVICES
  • CONTACT US
  1. Home
  2. PRODUCTS
  3. New Inhibitors&Agonists Polypeptide

Product Categories

New Inhibitors&Agonists Polypeptide Natural product Dye/Fluorescent agent ADC compound PROTAC compound Other compounds Nucleosides API Active Compounds and Other
Product ID Name Description Purity
TAC10665 tert-butyl 4-[5-bromo-6-[(1S)-1-methoxyethyl]pyridin-3-yl]piperazine-1-carboxylate 98.00%
TAC09407 tert-butyl 7-bromo-1,3,4,9-tetrahydro-2H-pyrido[3,
TAC00857 Tert-butyl(2e)-4-bromobut-2-enoate 98%+
TAC02571 tert-Butyl(5-(hydroxymethyl)pyridin-2-yl)carbamate 98%+
TAC08877 Tert-Butyl-d9-Amine 98%+
TAC08078 tert-Butyl3-(4-(methoxycarbonyl)phenyl)azetidine-1-carboxylate 98%+
TAC02380 tert-Butyl4-chloro-8,9-dihydro-5H-pyrimido[5,4-d]azepine-7(6H)-carboxylate 98%+
TAC06044 Tertiapin-Q 98%+
TAC00805 Terutroban 98%+
TAC00756 Tesirine 98%+
TAC09157 Testololactone 98%+
TAC01097 Tetrabenazine 98%+
TAC02296 tetrabutylazanium,nitrite 98%+
TAC01205 Tetracaine EP Impurity B 98%+
TAC07633 Tetrahydro 11-Deoxycorticosterone 98%+
TAC08676 Tetrahydrocorticosterone 98%+
TAC01380 Tetrahydrofuran 98%+
TAC01434 TETRAHYDROPALMATINEHYDROCHLORIDE 98%+
TAC08013 Tetramethylcurcumin 98%+
TAC04491 TETRAMETHYLRHODAMINE METHYL ESTER PERCHLORATE 98%+
  • 1
  • ...
  • 411
  • 412
  • 413
  • 414
  • 415
  • ...
  • 459
Contact Us

Ph: +86 180 14399 201
E-Mail:sales@chemlab-tachizaki.com
Add: Building C, 888 Huanhu West Second Road, Lingang New Area, China (Shanghai) Pilot Free Trade Zone

We respond quickly to your needs
Title
Company
E-mail
Name
CAS
Structural Formula
Quantity
Message:

CopyRight @2020- 2024 Shanghai Tachizaki Biomedical Research Center